Cytosorbents Statistics Share Statistics Cytosorbents has 62.76M
shares outstanding. The number of shares has increased by 14.47%
in one year.
Shares Outstanding 62.76M Shares Change (YoY) 14.47% Shares Change (QoQ) 0.24% Owned by Institutions (%) 26.26% Shares Floating 54.98M Failed to Deliver (FTD) Shares 7,553 FTD / Avg. Volume 4.44%
Short Selling Information The latest short interest is 1.35M, so 2.15% of the outstanding
shares have been sold short.
Short Interest 1.35M Short % of Shares Out 2.15% Short % of Float 2.33% Short Ratio (days to cover) 23.05
Valuation Ratios The PE ratio is -2.39 and the forward
PE ratio is -8.95.
Cytosorbents's PEG ratio is
0.06.
PE Ratio -2.39 Forward PE -8.95 PS Ratio 1.39 Forward PS 1.2 PB Ratio 4.46 P/FCF Ratio -3.37 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cytosorbents.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.2,
with a Debt / Equity ratio of 2.42.
Current Ratio 2.2 Quick Ratio 1.92 Debt / Equity 2.42 Debt / EBITDA -1.4 Debt / FCF -1.83 Interest Coverage -12
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $238.89K Profits Per Employee $-139.05K Employee Count 149 Asset Turnover 0.75 Inventory Turnover 3.83
Taxes Income Tax -1.69M Effective Tax Rate 7.55%
Stock Price Statistics The stock price has increased by -17.65% in the
last 52 weeks. The beta is 1.29, so Cytosorbents's
price volatility has been higher than the market average.
Beta 1.29 52-Week Price Change -17.65% 50-Day Moving Average 0.96 200-Day Moving Average 1.01 Relative Strength Index (RSI) 55.78 Average Volume (20 Days) 169,992
Income Statement In the last 12 months, Cytosorbents had revenue of 35.59M
and earned -20.72M
in profits. Earnings per share was -0.38.
Revenue 35.59M Gross Profit 25.13M Operating Income -16.79M Net Income -20.72M EBITDA -19.26M EBIT -21.01M Earnings Per Share (EPS) -0.38
Full Income Statement Balance Sheet The company has 3.28M in cash and 26.89M in
debt, giving a net cash position of -23.61M.
Cash & Cash Equivalents 3.28M Total Debt 26.89M Net Cash -23.61M Retained Earnings -304.01M Total Assets 47.99M Working Capital 13.14M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -14.43M
and capital expenditures -284.34K, giving a free cash flow of -14.71M.
Operating Cash Flow -14.43M Capital Expenditures -284.34K Free Cash Flow -14.71M FCF Per Share -0.27
Full Cash Flow Statement Margins Gross margin is 70.59%, with operating and profit margins of -47.16% and -58.21%.
Gross Margin 70.59% Operating Margin -47.16% Pretax Margin -62.96% Profit Margin -58.21% EBITDA Margin -54.11% EBIT Margin -47.16% FCF Margin -41.33%
Dividends & Yields CTSO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for CTSO is $10,
which is 920.4% higher than the current price. The consensus rating is "Hold".
Price Target $10 Price Target Difference 920.4% Analyst Consensus Hold Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 5, 2014. It was a
backward
split with a ratio of 1:25.
Last Split Date Dec 5, 2014 Split Type backward Split Ratio 1:25
Scores Altman Z-Score -8.12 Piotroski F-Score 2
